The only question remaining about South Korea (SK) is how far into the future will you continue to beat a dead horse? Apparently you have forgotten your own words in prior posts relating to SK. I opined about SK being a bust several months prior to management stating the company pulled out of SK in part due to a lack of patients. Dr. KSS went further to state there were regulatory issues in SK that were/became (for lack of the Egg Zack terminology used because I'm not going sdrawkcab to review it) problematic. Apparently, that's your ongoing job. We've done the two step over and over again about SK long enough tcm55. The music has stopped. Yet you're still dancing around a non-issue.
tcm55 11-29-20: I know we are not supporting the SK Ifenprodil CT any more
tcm55 11-17-20: I know we have left as a sponsor of the SK trials due to early success there in fighting Covid.
tm55 09-30-20: That Data could have made this but Novotec/SK 1/2 stepped/failed us.
tcm55 09-30-20: BTW FU Dr Sik ,SK.
Shall I keep going...better yet...should you keep going?
I have stated as far back as July 2020 the SK study was a bust.
News 
Market Data 
Discover 
